Contract award · 18 Dec 2025

NP49425 Generic and Biosimilar Transition Medicines: Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded a contract to Celltrion Healthcare United Kingdom…

Medical equipment & pharmaceuticalsScotland

Open competition

Open procedure: the contract was advertised and any supplier could submit a bid.

Key facts

Value
£64,103,740 across 10 lots
Procedure
Open procedure
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date18 Dec 2025
  2. Published19 Dec 2025Published 1 day after the contract date

Description

Supply of cytokine modulators (golimumab, tocilizumab, and etanercept) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

Lots in this award

LotSupplierValue
NP49425 Generic and Biosimilar Transition Medicines: Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)Celltrion Healthcare United Kingdom Limited SME, Fresenius Kabi Limited, Janssen-Cilag Ltd, Mercury Pharmaceuticals Limited SME, Roche Products Ltd£26.5m
NP49425 Generic and Biosimilar Transition Medicines: Psychiatry and Neurology MedicinesBrown and Burk, Lupin Healthcare UK Ltd£188k
NP49425 Generic and Biosimilar Transition Medicines: Cytokine Modulators (Omalizumab)Celltrion Healthcare United Kingdom Limited SME, Mercury Pharmaceuticals Limited SME£9.25m
NP49425 Generic and Biosimilar Transition Medicines: Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis MedicinesAccord Healthcare Ltd, Amarox Limited, AOP Orphan Ltd, Biocon Pharma UK Ltd, Celix Pharma Ltd. +15 more£3.59m
NP49425 Generic and Biosimilar Transition Medicines: Denosumab (Osteoporosis) and Ferric CarboxymaltoseAccord Healthcare Ltd, Celltrion Healthcare United Kingdom Limited SME, Dr Reddy's Laboratories (UK) Ltd, Fresenius Kabi Limited, Gedeon Richter UK Ltd +6 more£2.25m
NP49425 Generic and Biosimilar Transition Medicines: ApremilastAccord Healthcare Ltd, Celix Pharma Ltd., STADA UK - Thornton & Ross, Teva UK Ltd£664k
NP49425 Generic and Biosimilar Transition Medicines: Cardiovascular and Respiratory MedicinesBrown and Burk, Celix Pharma Ltd., CST Pharma Ltd, STADA UK - Thornton & Ross, Teva UK Ltd +2 more£78,009
NP49425 Generic and Biosimilar Transition Medicines: NintedanibAccord Healthcare Ltd, Celix Pharma Ltd., Dr Reddy's Laboratories (UK) Ltd, Mercury Pharmaceuticals Limited SME, Teva UK Ltd +1 more£1.4m
NP49425 Generic and Biosimilar Transition Medicines: Cancer Medicines (Group 1)Accord Healthcare Ltd, Ferring Pharmaceuticals Limited, Glenmark Pharmaceuticals Europe Ltd, Pfizer, STADA UK - Thornton & Ross +2 more£1.93m
NP49425 Generic and Biosimilar Transition Medicines: Cancer Medicines (Group 2)Accord Healthcare Ltd, Amgen Ltd, Celltrion Healthcare United Kingdom Limited SME, Dr Reddy's Laboratories (UK) Ltd, Fresenius Kabi Limited +6 more£18.2m

About the suppliers

More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

All contracts

More won by Celltrion Healthcare United Kingdom Limited

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview